Levi & Korsinsky, LLP announces that a LCI class action lawsuit has been filed on behalf of investors who purchased Lannett Company, Inc. (LCI) securities between February 7, 2018 and August 17, 2018. For more on the LCI Lawsuit please contact us today.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Lannett faced a substantial risk of the loss of its exclusivity agreement with Jerome Stevens Pharmaceuticals; (2) accordingly, Lannett’s reported revenues were unsustainable; and (3) as a result, Lannett’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in you have until October 26, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.